EIF2AK2 and cancer: G207 is an oncolytic recombinant replication-competent HSV-1 which has two modifications to increase specificity towards GBM cells: deletions in both copies of the RL1 gene to target PKR-defective cancer cells and disruption of UL39 gene to eliminate the possibility to replicate in non-dividing normal cells.